Knowledge transfer and translation: Examining how teratogen information is disseminated

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 11, 2011, Pages 956-961

  Shahin, Ilan ^a   Einarson, Adrienne ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Knowledge; Teratology; Transfer; Translation

Indexed keywords

ARTICLE; HEALTH CARE PERSONNEL; INFORMATION DISSEMINATION; INFORMATION RETRIEVAL; MEDICAL EDUCATION; MEDICAL INFORMATION; PEER REVIEW; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; TERATOGENESIS; TERATOGENICITY; TERATOLOGY;

ABNORMALITIES, DRUG-INDUCED; DATABASES, FACTUAL; DRUG INFORMATION SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; INFANT; INFORMATION DISSEMINATION; INTERNET; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; TERATOGENS; TERATOLOGY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80855147825     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.22851     Document Type: Article

References (62)

1. Abramsky L, Fletcher O. 2002. Interpreting information: what is said, what is heard-a questionnaire study of health professionals and members of the public. Prenat Diagn 22: 1188-1194.
2. Attard CL, Kohli MA, Coleman S, et al. 2002. The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol 186( 5 Suppl Understanding): S220-S227.
3. Baggley A, Navioz Y, Maltepe C, et al. 2004. Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically. J Midwifery Womens Health 49: 350-354.
4. Bailey B, Forget S, Koren G. 2002. Pregnancy outcome of women who failed appointments at a teratogen information service clinic. Reprod Toxicol 16: 77-80.
5. Bakhireva LN, Schatz M, Jones KL, et al. 2008. Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann Allergy Asthma Immunol 101: 137-143.
6. Baylis F. 2010. Pregnant women deserve better. Nature 465: 689-690.
7. Beaudet A. 2010. Message from the president: budget 2010. Canadian Institutes of Health Research.
8. Bentur Y. 2001. Ionizing and nonionizing radiation in pregnancy. In: Koren G, editor. Maternal-fetal toxicology: a clinician's guide.3 ed. New York, NY: Marcel Dekker. pp 603-651.
9. Bentur Y, Horlatsch N, Koren G. 1991. Exposure to ionizing radiation during pregnancy: perception of teratogenic risk and outcome. Teratology 43: 109-112.
10. Brent R. 2003. Bendectin and birth defects: hopefully, the final chapter. Birth Defects Res A Clin Mol Teratol 67: 79-87.
11. Charlett D, Garland R, Mar N. 1995. How damaging is negative word of mouth. Marketing Bulletin 6: 42-50.
12. Canadian Institute for Health Research. 2004. Knowledge Translation Strategy 2004-2009. Innovation in Action. Ottawa: Canadian Institutes of Health Research.
13. Cohen JS. 2001. Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events. Arch Intern Med 161: 957-964.
14. Cohen LS, Altshuler LL, Harlow BL, et al. 2006. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295: 499-507.
15. Damase-Michel C, Pichereau J, Pathak A, et al. 2008. Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area. Pharmacy Practice 6: 15-19.
16. De Santis M, Straface G, Cavaliere A, et al. 2006. Teratological risk evaluation and prevention of voluntary abortion. Minerva Ginecol 58: 91-99.
17. Doering PL, Boothby LA, Cheok M. 2002. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol 187: 333-339.
18. Einarson A, Bailey B, Jung G, et al. 1997. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 78: 183-186.
19. Einarson A, Park A, Koren G. 2004. How physicians perceive and utilize information from a teratogen information service: the Motherisk Program. BMC Med Educ 4: 6.
20. Einarson A, Schachtschneider A, Halil R, et al. 2005. SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy Childbirth 5: 11.
21. Einarson A, Selby P, Koren G. 2001. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 26: 44-48.
22. Glover DD, Amonkar M, Rybeck BF, Tracy TS. 2003. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 188: 1039-1045.
23. Hancock RL, Ungar WJ, Einarson A, et al. 2008. Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services. Reprod Toxicol 25: 381-387.
24. Hart C, Heskett J, Sasser W. 1990. The profitable art of service recovery: how the best companies turn complaining customers into loyal ones. Harvard Business Review.
25. Health Canada Online. Health Canada advises of potential adverse effects of SSRI's and other antidepressants on newborns. Health Canada Online.
26. Hemels ME, Einarson A, Koren G, et al. 2005. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 39: 803-809.
27. Henshaw SK. 1998. Unintended pregnancy in the United States. Fam Plann Perspect 30: 24-29.
28. Hu G, Sun Z. 2008. Poor knowledge translation: an urgent problem in China. Lancet 372: 718.
29. Institute of Medicine. 2001. Crossing the quality chasm: a new health system for the twenty-first century. Washington: National Academy Press.
30. Jasper JD, Goel R, Einarson A, et al. 2001. Effects of framing on teratogenic risk perception in pregnant women. Lancet 358: 1237-1238.
31. Kelsey FO. 1982. Regulatory aspects of teratology: role of the Food and Drug Administration. Teratology 25: 193-199.
32. Koren G, Levichek Z. 2002. The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk. Am J Obstet Gynecol 186( 5 Supplement Understanding): S248-S252.
33. Koren G, Pastuszak A. 1990. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. Teratology 41: 657-661.
34. Lang ES, Wyer PC, Haynes RB. 2007. Knowledge translation: closing the evidence-to-practice gap. Ann Emerg Med 49: 355-363.
35. Lavis JN, Ross SE, Hurley JE, et al. 2002. Examining the role of health services research in public policymaking. Milbank Q 80: 125-154.
36. Law R, Bozzo P, Koren G, Einarson A. 2010. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician 56: 239-241.
37. Leen-Mitchell M, Martinez L, Gallegos S, et al. 2000. Mini-review: history of organized teratology information services in North America. Teratology 61: 314-317.
38. Lloyd AJ. 2001. The extent of patients' understanding of the risk of treatments. Qual Health Care 10 Suppl 1: i14-i18.
39. Ministry of Science and Technology of China. 2007. Summary of academic publications of China in 2006.
40. Moynihan R, Bero L, Ross-Degnan D, et al. 2000. Coverage by the news media of the benefits and risks of medications. N Engl J Med 342: 1645-1650.
41. Nordeng H, Ystrøm E, Einarson A. 2010. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 66: 207-214.
42. Office of Women's Health. 2010. Pregnancy and medicines. Office of Women's Health.
43. Organization of Teratology Information Specialists. 2010a. About us- organization of teratogen information specialists. Organization of Teratogen Specialists.
44. Organization of Teratology Information Specialists. 2010b. Home page- organization of teratogen information specialists. Organization of Teratogen Specialists.
45. Organization of Teratology Information Specialists. Unknown date. Organization of teratology information specialists-report of activities 2007-2009. Organization of Teratology Specialists.
46. Piwko C, Ungar WJ, Einarson TR, et al. 2007. The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program. Curr Med Res Opin 23: 833-840.
47. Prosser H. 2010. Marvelous medicines and dangerous drugs: the representation of prescription medicine in the UK newsprint media. Public Underst Sci 19: 52-69.
48. Public Affairs Committee of the Teratology Society. 2007. Teratology public affairs committee position paper: pregnancy labeling for prescription drugs: ten years later. Birth Defects Res A Clin Mol Teratol 79: 627-630.
49. Ramos E, St-André M, Rey E, et al. 2008. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 192: 344-350.
50. Ratnapalan S, Bona N, Chandra K, Koren G. 2004. Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol 182: 1107-1109.
51. Scanfeld D, Scanfeld V, Larson EL. 2010. Dissemination of health information through social networks: twitter and antibiotics. Am J Infect Control 38: 182-188.
52. Schaefer C, Hannemann D, Meister R. 2005. Post-marketing surveillance system for drugs in pregnancy-15 years experience of ENTIS. Reprod Toxicol 20: 331-343.
53. Schwarz EB, Santucci A, Borrero S, et al. 2009. Perspectives of primary care clinicians on teratogenic risk counseling. Birth Defects Res A Clin Mol Teratol 85: 858-863.
54. Shahin I. 2008. Managing the psychology of care: what it means and what it is worth. Mcgill J Med 11: 191-198.
55. Shuchman M, Wilkes MS. 1997. Medical scientists and health news reporting: a case of miscommunication. Ann Intern Med 126: 976-982.
56. Simpson E, Wittet S, Bonilla J, et al. 2007. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries. BMC Public Health 7: 281.
57. Statistics Canada. 2005. Induced Abortion Statistics- induced abortions, by area of report and type of facility performing the abortion (table). Statistics Canada.
58. Steer RA, Scholl TO, Hediger ML, Fischer RL. 1992. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 45: 1093-1099.
59. Sung NS, Crowley WF Jr, Genel M, et al. 2003. Central challenges facing the national clinical research enterprise. JAMA 289: 1278-1287.
60. The Hill Group. 2011. 4th Annual NIH Conference on the Science of Dissemination and Implementation. The Hill Group.
61. The University of Texas Health Science Center in Houston. 2011. Metformin versus insulin in pregnant women with type 2 diabetes. Clinicaltrials. gov.
62. Zuckerman B, Bauchner H, Parker S, Cabral H. 1990. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 11: 190-194.